RAQUEL
RIVERA DÍAZ
Profesora asociada de Ciencias de la Salud
Hospital Universitario La Paz
Madrid, EspañaHospital Universitario La Paz-ko ikertzaileekin lankidetzan egindako argitalpenak (24)
2024
-
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting
International Journal of Dermatology, Vol. 63, Núm. 4, pp. 503-511
-
Family Planning Concerns Among Women With Psoriasis: A Descriptive, Cross-Sectional, Multicenter Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 1, pp. 10-20
-
Four-year maintenance of complete skin clearance with bimekizumab in 10 Spanish patients from the BE RADIANT trial
Actas Dermo-Sifiliograficas
-
No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients
Journal of the European Academy of Dermatology and Venereology
2023
-
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population
Australasian Journal of Dermatology, Vol. 64, Núm. 4, pp. e317-e326
-
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 12, pp. 2517-2525
-
Generalized pustular psoriasis: practical recommendations for Spanish primary care and emergency physicians
Postgraduate Medicine, Vol. 135, Núm. 8, pp. 766-774
-
High adherence to secukinumab in patients with moderate to severe psoriasis: a long-term multicenter study in a daily practice setting
International Journal of Dermatology
2022
-
Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting
Dermatologic Therapy, Vol. 35, Núm. 8
-
Secukinumab is effective and safe in the long-term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients
Dermatologic Therapy, Vol. 35, Núm. 12
-
Unmet needs in patients with moderate-to-severe plaque psoriasis treated with methotrexate in real world practice: FirST study
Journal of Dermatological Treatment, Vol. 33, Núm. 3, pp. 1329-1338
-
Ustekinumab to guselkumab transitions: A series of 54 patients emulating the navigate trial in real life
Dermatologic Therapy, Vol. 35, Núm. 10
2021
-
Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study
Journal of the European Academy of Dermatology and Venereology
-
Management of Psoriasis During Preconception, Pregnancy, Postpartum, and Breastfeeding: A Consensus Statement
Actas Dermo-Sifiliograficas, Vol. 112, Núm. 3, pp. 225-241
-
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain
Dermatology and Therapy, Vol. 11, Núm. 6, pp. 2207-2215
2020
-
Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group
Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 12, pp. 2821-2829
-
The Use of Apremilast in Psoriasis: A Delphi Study
Actas Dermo-Sifiliograficas, Vol. 111, Núm. 2, pp. 115-134
2019
-
Osteoporosis and Psoriasis
Actas Dermo-Sifiliograficas
2018
-
Position statement for the management of comorbidities in psoriasis
Journal of the European Academy of Dermatology and Venereology, Vol. 32, Núm. 12, pp. 2058-2073
2017
-
Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease
Actas Dermo-Sifiliograficas